Head-To-Head Review: Waters (NYSE:WAT) and ADB International Group (OTCMKTS:EQUR)

ADB International Group (OTCMKTS:EQUR) and Waters (NYSE:WAT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Valuation & Earnings

This table compares ADB International Group and Waters”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ADB International Group	N/A	N/A	N/A	N/A	N/A
Waters	$3.17 billion	9.38	$642.63 million	$10.77	28.11

Waters has higher revenue and earnings than ADB International Group.

Insider & Institutional Ownership

94.0% of Waters shares are held by institutional investors. 79.6% of ADB International Group shares are held by company insiders. Comparatively, 0.6% of Waters shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares ADB International Group and Waters’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ADB International Group	N/A	N/A	N/A
Waters	20.30%	34.79%	16.29%

Analyst Ratings

This is a summary of current ratings and recommmendations for ADB International Group and Waters, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ADB International Group	0	0	0	0	0.00
Waters	0	9	10	2	2.67

Waters has a consensus target price of $394.63, suggesting a potential upside of 30.36%. Given Waters’ stronger consensus rating and higher probable upside, analysts plainly believe Waters is more favorable than ADB International Group.

Summary

Waters beats ADB International Group on 9 of the 10 factors compared between the two stocks.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.